Details of the Drug Reposition

General Information of This Drug (ID: DM4CXE2)

Drug Name
CAR-20/19-T Cells   DM4CXE2
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 1 [1]
B-cell non-hodgkin lymphoma DISUB5FB 2B33.5 Phase 1 [1]
Pancreatic cancer DISJC981 2C10 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03375619) Long-term Follow-up Study of Patients Receiving CAR-20/19-T Cells